Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 82

Sort by

Sort Order Select

Journal Articles

Targeted, Low Cost Epigenetic Microarray for AML and MDS Detection

Blood (2024) 144 (Supplement 1): 6142.

https://doi.org/10.1182/blood-2024-208540

Published: 2024

Journal Articles

Treatment Modalities and Outcomes of Multiple Myeloma Patients with Spinal Cord Compression: A Single Center Experience

Tamir Shragai, Yael Illouz, Natan Melamed, Svetlana Trestman, Moshe Mittelman, Inna Zetserov, Irit Mazza Avivi, Yael C. Cohen

Blood (2024) 144 (Supplement 1): 6932.

https://doi.org/10.1182/blood-2024-207068

Published: 2024

Journal Articles

A Phase 2B, Open-Label Multicenter Study of Tebapivat (AG-946), a Potent Pyruvate Kinase Activator, in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes

Amer M. Zeidan, Mikkael A. Sekeres, Hanny Al-Samkari, Hetty E. Carraway, Amy E. DeZern, Moshe Mittelman, Meredith Little, Vanessa Beynon, Xiaoshu Dai, Sal Sommakia, Jenny M. Despotovic, Parija Patel, Melissa Dibacco, Bruno Fattizzo, Eytan M. Stein, David Sallman, Austin G. Kulasekararaj, Uwe Platzbecker, Pierre Fenaux

Blood (2024) 144 (Supplement 1): 6708.

https://doi.org/10.1182/blood-2024-203073

Published: 2024

Journal Articles

Effect of Prior Treatments on the Clinical Activity of Imetelstat in Transfusion-Dependent Patients with Erythropoiesis-Stimulating Agent, Relapsed or Refractory/Ineligible Lower-Risk Myelodysplastic Syndromes

Blood (2024) 144 (Supplement 1): 352.

https://doi.org/10.1182/blood-2024-203612

Published: 2024

Journal Articles

Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study

Moshe Mittelman, David H. Henry, John Glaspy, Anil Tombak, Rosemary Anne Harrup, Krzysztof Madry, Barbara Grabowska, Uwe Platzbecker, Tyson Lee, Katharina Modelska

Blood (2023) 142 (Supplement 1): 195.

https://doi.org/10.1182/blood-2023-180749

Published: 2023

Journal Articles

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib, Pomalidomide and Dexamethasone Combination As Second or Third-Line Treatment for Triple-Class Exposed Patients with Relapsed and Refractory Multiple Myeloma (iPod-790 Trial)

Yael C. Cohen, Tamir Shragai, Noa Lavi, Iuliana Vaxman, Evgeni Chubar, Moshe E Gatt, Chezi Ganzel, Hila Magen, Efrat Luttwak, Moshe Mittelman, Inna Tzoran, Vladimir Vainstein, Noa Lowenton-Spier, Natan Melamed, Ella Krayzler, Ilana Pereg, Irit Avivi Mazza

Blood (2023) 142 (Supplement 1): 2014.

https://doi.org/10.1182/blood-2023-185830

Published: 2023

Journal Articles

Do We Still Need to Perform Bone Marrow Examination in All Subjects Suspected of MDS? Evaluation and Validation of Non-Invasive (Web-Based) Algorithm

Howard S Oster, Ariel M Polakow, Noa Goldschmidt, Moshe Mittelman

Blood (2023) 142 (Supplement 1): 6475.

https://doi.org/10.1182/blood-2023-178713

Published: 2023

Journal Articles

Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience

Yakir Moshe, Shai Levi, Miriam Neaman, Roi Gat, Mor Levi, Nili Eilati, Gil Fridberg, Yotam Bornstein, Tamir Shragai, Tsipora Neuman, Roy Vitkon, Eliya Shachar, David Sarid, Ofer Merimsky, Moshe Mittelman, Irit Avivi Mazza

Blood (2023) 142 (Supplement 1): 5929.

https://doi.org/10.1182/blood-2023-186234

Published: 2023

Journal Articles

Yoga As Possible Non-Medical Intervention to Improve Quality of Life of Patients with Myelodysplastic Syndromes - a Feasibility Report

Irina Amitai, Ilana Hellmann, Maya Koren-Michowitz, Tsila Zuckerman, Ariel Aviv, Anatoly Nemets, Itai Levi, Yishai Ofran, Moshe Mittelman, Drorit Grizim Merkel

Blood (2022) 140 (Supplement 1): 12349–12350.

https://doi.org/10.1182/blood-2022-166542

Published: 2022

Journal Articles

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

Blood (2022) 140 (Supplement 1): 9802–9803.

https://doi.org/10.1182/blood-2022-167716

Published: 2022

Journal Articles

Erythropoietin Administration Delays B Cell Maturation and Promotes B Cell to Erythroid Transdifferentiation in Mice

Albert Kolomansky, Anton Gorodov, Stav Kislev, Nathalie Ben-Califa, Alana Starr, Yankel Gabet, Martina Rauner, Ben Wielockx, Moshe Mittelman, Howard S. Oster, Drorit Neumann

Blood (2022) 140 (Supplement 1): 1241–1242.

https://doi.org/10.1182/blood-2022-167848

Published: 2022

Journal Articles

Can We Identify Individuals at Risk to Develop Multiple Myeloma? a Machine Learning Based Predictive Model

Moshe Mittelman, Howard S. Oster, Yatir Ben Shlomo, Ariel Israel, Osnat Jarchowcky Dolberg, Samah Hayek, Michael Leshchinsky, Eldad Kepten, Ran Balicer, Galit Shaham

Blood (2022) 140 (Supplement 1): 7259–7260.

https://doi.org/10.1182/blood-2022-162438

Published: 2022

Journal Articles

Validation of a Novel Algorithm with a High Specificity in Ruling out MDS

Felicitas Schulz, Kathrin Nachtkamp, Howard S. Oster, Moshe Mittelman, Norbert Gattermann, Carmen Barthuber, Sarah Schweier, Ulrich Germing

Blood (2022) 140 (Supplement 1): 9789–9790.

https://doi.org/10.1182/blood-2022-163431

Published: 2022

Journal Articles

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting

Moshe Mittelman, Ori Magen, Noam Barda, Noa Dagan, Howard S. Oster, Avi Leader, Ran Balicer

Blood (2022) 139 (10): 1439–1451.

https://doi.org/10.1182/blood.2021013768

Published: 2022

Includes: Supplemental data

Journal Articles

Automated Digital Morphometry of Peripheral Blood Smears Detects Both Infrequent Events and Cellular Population Patterns in Myelodysplastic Syndrome

Ben Zion Katz, Shahar Karni, Hadar Shimoni, Amit Natan, Amir Shaham, Dan Benisty, Olga Pozdnyakova, Merav Barzilai, Moshe Mittelman, Irit Avivi

Blood (2021) 138 (Supplement 1): 3999.

https://doi.org/10.1182/blood-2021-147750

Published: 2021

Journal Articles

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Fabio Efficace, Karin A Koinig, Francesco Cottone, David Bowen, Moshe Mittelman, Saskia M. C. Langemeijer, Dominic Culligan, Kalman Filanovsky, Gregory A. Abel, Michael Storck, Alexandra Smith, Corine Van Marrewijk, Martin Dugas, Theo M de Witte, Reinhard Stauder

Blood (2021) 138 (Supplement 1): 1982.

https://doi.org/10.1182/blood-2021-147176

Published: 2021

Journal Articles

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

Blood (2021) 138 (Supplement 1): 4671.

https://doi.org/10.1182/blood-2021-150322

Published: 2021

Journal Articles

Patients Diagnosed with Myelodysplastic Syndromes Display Lower Bone Mass: Assessment Using Bone Marrow Biopsies Manually and with Artificial Intelligence

Albert Kolomansky, Roy Malka, Edo Cohen-Karlik, Gal Barequet, Sagi Tauber, Itay Kalev, Ruben Wolhandler, Yoav Gaulan, Roee Esquira, Moni Shahar, Yishai Mansour, Amir Globerson, Drorit Neumann, Moshe Mittelman, Howard S. Oster

Blood (2021) 138 (Supplement 1): 3694.

https://doi.org/10.1182/blood-2021-149575

Published: 2021

Journal Articles

Quality of Life Is Impaired in Anemic MDS Patients, and May Still Remain Poor Even When Hemoglobin Improves

Yael Haring, Nitzan Cohen Sagy, Shaimaa Taha, Albert Kolomansky, Howard S. Oster, Moshe Mittelman

Blood (2021) 138 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2021-148627

Published: 2021

Journal Articles

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-138549

Published: 2020

NARROW

Targeted, Low Cost Epigenetic Microarray for AML and MDS Detection

Treatment Modalities and Outcomes of Multiple Myeloma Patients with Spinal Cord Compression: A Single Center Experience

A Phase 2B, Open-Label Multicenter Study of Tebapivat (AG-946), a Potent Pyruvate Kinase Activator, in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes

Effect of Prior Treatments on the Clinical Activity of Imetelstat in Transfusion-Dependent Patients with Erythropoiesis-Stimulating Agent, Relapsed or Refractory/Ineligible Lower-Risk Myelodysplastic Syndromes

Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study

A Phase II Multicenter Clinical Trial Assessing the Safety and Efficacy of Ixazomib, Pomalidomide and Dexamethasone Combination As Second or Third-Line Treatment for Triple-Class Exposed Patients with Relapsed and Refractory Multiple Myeloma (iPod-790 Trial)

Do We Still Need to Perform Bone Marrow Examination in All Subjects Suspected of MDS? Evaluation and Validation of Non-Invasive (Web-Based) Algorithm

Outcomes of Acute Myeloid Leukemia Patients Suffering from an Additional Active Malignancy Treated with Venetoclax and Azacitidine: A Single Center Experience

Yoga As Possible Non-Medical Intervention to Improve Quality of Life of Patients with Myelodysplastic Syndromes - a Feasibility Report

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

Erythropoietin Administration Delays B Cell Maturation and Promotes B Cell to Erythroid Transdifferentiation in Mice

Can We Identify Individuals at Risk to Develop Multiple Myeloma? a Machine Learning Based Predictive Model

Validation of a Novel Algorithm with a High Specificity in Ruling out MDS

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting

Automated Digital Morphometry of Peripheral Blood Smears Detects Both Infrequent Events and Cellular Population Patterns in Myelodysplastic Syndrome

Validation of the Qualms Questionnaire to Assess Health-Related Quality of Life in European and Israeli Patients with Myelodysplastic Syndromes: Results from the MDS-Right Project

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

Patients Diagnosed with Myelodysplastic Syndromes Display Lower Bone Mass: Assessment Using Bone Marrow Biopsies Manually and with Artificial Intelligence

Quality of Life Is Impaired in Anemic MDS Patients, and May Still Remain Poor Even When Hemoglobin Improves

Mutation Profiles Identify Distinct Clusters of Lower Risk Myelodysplastic Syndromes with Unique Clinical and Biological Features and Clinical Endpoints

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only